Surgery Partners, INC Schedule 13G passive stakes

King Street Capital Management, L.P. and its affiliates have reported beneficial ownership of 4.6% of Surgery Partners, Inc. common stock as of June 30, 2026.

FMR LLC, through its subsidiaries, has reported beneficial ownership of 2,191,465.08 shares of Surgery Partners Inc. common stock, representing 1.7% of the class.

The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in Surgery Partners Inc. following an internal corporate realignment.

FMR LLC and its affiliates, including Abigail P. Johnson, reported a continued 5.1% beneficial ownership stake in Surgery Partners Inc. as of December 31, 2025.

Pentwater Capital Management LP and Matthew Halbower have disclosed a 9.1% beneficial ownership stake in Surgery Partners, Inc., totaling 11,681,000 shares.

Janus Henderson Group plc and its affiliates reported a beneficial ownership of 10.2% in Surgery Partners, Inc. common stock as of September 30, 2025.

King Street Capital Management and its affiliates have reported a 7.2% beneficial ownership stake in Surgery Partners, Inc., holding 9,339,930 shares of common stock.

Pentwater Capital Management LP and Matthew Halbower have disclosed a 5.5% beneficial ownership stake in Surgery Partners, Inc. common stock.

Wellington Management Group and its affiliates have filed an amended Schedule 13G, disclosing a 0.0% beneficial ownership in Surgery Partners, Inc.

Janus Henderson Group plc and its affiliate, Janus Henderson Contrarian Fund, have reported an increased beneficial ownership in Surgery Partners, Inc., holding an aggregate of 12,954,916 shares, representing 10.1% of the common stock as of June 30, 2025.

Janus Henderson Group PLC and its affiliate, Janus Henderson Contrarian Fund, have filed an amended Schedule 13G, disclosing a combined beneficial ownership of 9.1% in Surgery Partners, Inc. as of March 31, 2025.

Wellington Management Group LLP and its affiliates have disclosed a beneficial ownership of 5.56% of Surgery Partners, Inc.'s common stock, held in the ordinary course of business.

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a continued beneficial ownership of 7.9% of Surgery Partners Inc.'s common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.4% beneficial ownership stake in Surgery Partners, Inc. as of March 31, 2025, indicating a passive investment.

FMR LLC and its affiliates, along with Abigail P. Johnson, have reported a continued beneficial ownership of 12.7% of Surgery Partners Inc.'s common stock as of December 31, 2024.

Wellington Management Group LLP and its affiliates have disclosed a beneficial ownership of 4.66% of Surgery Partners, Inc. common stock as of December 31, 2024, held in the ordinary course of business.

Janus Henderson Group plc has filed a Schedule 13G, revealing a beneficial ownership of 9.5% of Surgery Partners, Inc.'s common stock, held for investment purposes.